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INTRODUCTION
Stress urinary incontinence (SUI), defined as the involun-
tary leakage of urine on effort or exertion, or on sneezing or
coughing, is a common embarrassing condition that primar-
ily affects women. The two epidemiologic factors most strong-
ly associated with the development of SUI in women are par-
ity and advanced age (1, 2). Although the exact mechanism
of SUI in elderly postpartum women is poorly understood,
two principal causes of SUI have been postulated: 1) lack of
sufficient support around the urethra that can lead to increased
movement or ‘hypermobility’ and 2) a weakness in the ure-
thral sphincter that controls the passage of urine, known as
‘intrinsic sphincter deficiency’ (ISD) due to both neuromus-
cular and connective tissue injuries (3). Especially ISD is known
to be closely related to the injury to the internal rhabdosphinc-
ter, such as obstetric trauma or surgical injury. A direct cor-
relation has recently been noted between the frequency of
urinary incontinence and apoptosis of the urethral sphincter
cells. Decreased muscle cell numbers caused by age-depen-
dent spontaneous apoptosis of muscle cells may also be an
important factor in stress urinary incontinence in both men
and women. Thus, ISD can be regarded as a type of degen-
erative disease with decreased ability to recover or regener-
ate the damaged sphincter that may result in the failure of
proper tissue reconstruction (4-6). 
The notion of ISD as a degenerative disease provided the
theoretical ground for stem cell therapy in ISD in some ani-
mal model studies with the prospect that the stem cells may
play a role in regenerating the damaged sphincter. Stem cell
application in the treatment of ISD has been tried with mus-
cle-derived progenitor cells or satellite cells, the alleged stem
cells for skeletal muscle. In addition, tissue engineering using
muscle cells is also an area of active research that may pre-
sent exciting treatment options for urologic diseases (7-10).
However, previous stem cell treatments were not entirely
successful due to some issues. First, cultivated and extracted
stem cells from the aged patient’s own muscle do not grow
well after transplantation. Second, the muscle extraction pro-
cess is invasive and may cause complications of bleeding or
infection at the surgery site.
We expected that human umbilical cord blood (HUCB) can
be a better source of adult stem cells as it is not associated with
the problems of other stem cell therapies mentioned above
and it can be safely used without significant side effects. Here,
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Human Umbilical Cord Blood Mononuclear Cell Transplantation 
in Rats with Intrinsic Sphincter Deficiency
To evaluate the effectiveness of the human umbilical cord blood (HUCB) transplan-
tation for the treatment of intrinsic sphincter deficiency (ISD), we analyzed the short
term effects of HUCB mononuclear cell transplantation in rats with induced-ISD. ISD
was induced in rats by electro-cauterization of periurethral soft tissue with HUCB
mononuclear cell injection after 1 week. The sphincter function measured by mean
leak point pressure was significantly improved in the experimental group compared
to the control group at 4 weeks. (91.75±18.99 mmHg vs. 65.02±22.09 mmHg,
P=0.001). Histologically, the sphincter muscle was restored without damage while
in the control group it appeared markedly disrupted with atrophic muscle layers and
collagen deposit. We identified injected HUCB cells in the tissue sections by Di-I
signal and Prussian blue staining. HUCB mononuclear cell injection significantly
improved urethral sphincter function, suggesting its potential efficacy in the treat-
ment of ISD.
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structure to evaluate its efficacy in the treatment of ISD.
MATERIALS AND METHODS
Human umbilical cord blood sample collection and ani-
mal handling for this experiment were performed in com-
pliance with laws and institutional guidelines approved by
the Institutional Animal Care and Use Committee from CHA
Gangnam Medical Center and School of Medicine, CHA Uni-
versity. This study was carried out from June 2005 to Septem-
ber 2006 at the CHA Gangnam Medical Center and School
of Medicine, CHA University.
Animals
All experiments were performed on normal female, 5-6
week-old Sprague-Dawley rats (Orient Bio Inc. Seongnam,
Korea), weighing 200 to 250 g. ISD was induced by electro-
cauterization in all animals. One week after electro-cauteri-
zation, the animals were injected with either HUCB mononu-
clear cells (experimental group, n=28) or normal saline (con-
trol group, n=22). The rats were kept in individual cages and
had free access to water and food. Eight and 14 rats from the
control group and 9 and 19 rats from the experimental group
were studied at 2 and 4 weeks after injection, respectively.
Induction of ISD by electro-cauterization 
ISD was induced by electro-cauterization as previously des-
cribed (8, 11). Briefly, rats were anesthetized by intraperi-
toneal injection of ketamine hydrochloride (100 mg/kg) and
xylazine hydrochloride (15 mg/kg). Under anesthesia, they
were placed in the supine position with the lower legs abduct-
ed. The bladder and urethra were exposed through a lower
midline abdominal incision. Tissues, 1 cm lateral to the mid-
urethra were cauterized on both sides to produce sphincter
injury. A fine tip, high-temperature cautery (Aaron Medical,
St. Petersburg, FL, USA) was used. Each side was cauterized
for 30 sec.
Human umbilical cord blood mononuclear cell separation 
After thawing at 37℃, cord blood cells were separated
into a low-density mononuclear fraction (<1,077 g/mL) by
Ficoll-Paque Plus (GE Healthcare AB, Uppsala, Sweden,
http://www.amersham.com). Briefly, after adding and mix-
ing the same amount of normal saline into the cord blood,
poured the diluted solution on Ficoll in 15 mL tubes (Ficoll:
diluted blood=3:4), and centrifuged at 1,800 rpm for 30 min.
After carefully extracting the mononuclear cells from the
mononuclear cell layer on the Ficoll, gathered the cells in
50 mL tubes and added a 3×volume of normal saline and
collected the target cells by centrifugation at 1,800 rpm for
10 min. After removing the upper layer solution, 50 mL of
normal saline was added and mixed into the remaining cell
pellet and two more centrifugation processes at 1,000 rpm
for 10 min were performed. Finally, the cell pellet with 50
mL of normal saline was elutriated and cell counting in 10 mL
of the suspension was performed.
Labeling of human umbilical cord blood mononuclear cells
To track the migration and engraftment of HUCB mononu-
clear cells at the site of injection, cells were double labeled
with iron oxides and the fluorescent cell tracker 1,10-dioc-
tadecyl-3,3,3′ ,3′ -tetramethylindocarbocyanine perchlorate
(DiI) dye according to the method developed by Arbab et al.
(12). Briefly, HUCB mononuclear cells were grown in 75 cm2
culture flasks to 80-90% confluence before labeling with iron
oxides (Feridex
�, Berlex Laboratories Inc., Wayne, NJ, USA)
and fluorescent dye DiI (Molecular Probes, Eugene, OR, USA).
On the day of labeling, the old media was discarded, replaced
by 50% of fresh complete BMSC media and 50% serum free
media containing iron oxides-protamine sulfate complexes
(50 and 2 mg/mL, respectively), and incubated overnight. Cells
were harvested and resuspended in serum free media at a con-
centration of 1-2 million/mL. 1×106 iron-labeled cells were
further labeled with fluorescent tracker DiI (Cell tracker CM-
DiI, C-7000; Molecular Probes) dye for 30 min at 37℃ in
1 mL of serum-free medium containing 10 mL of DiI stock
solution. After labeling with DiI, cells were washed twice
with PBS before injection. Cell viability was established by
the Trypan blue exclusion method before and after fluores-
cent labeling.
Human umbilical cord blood mononuclear cell injection
One week after electro-cauterization, the experimental rats
underwent ketamine/xylazine anesthesia and a low midline
incision was made to expose the bladder and urethra. A 30 mL
Hamilton syringe was used to inject a total of 20 mL of HUCB
mononuclear cell suspension in saline solution (2×106 cells
per 20 mL). Two injections per rat (10 mL each) were performed
on each lateral wall of the mid-urethra and then the abdomen
was sutured. Control rats were injected with normal saline
only.
Leak point pressure measurement
At 2 and 4weeks after HUCB mononuclear cells injection
the leak point pressure (LPP) were measured using the ver-
tical tilt/intravesical pressure clamp model of stress urinary
incontinence (11). The animals were anesthetized with ure-
thane (1.2 g/kg) injected subcutaneously. And all rats under-
went spinal cord transection at the T9-T10 level following
laminectomy in order to eliminate spontaneous bladder activity
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tion does not interfere with the spinal continence reflexes of
the bladder neck and urethra. The overlying skin was then
closed with a suture. Next, through a midline abdominal inci-
sion the distal colon was cleared of feces by gentle massage,
and a loose suture was secured around the proximal end of the
distal colon to prevent further fecal migration to the pelvic floor
during the course of the experiment. A transvesical catheter
with a fire-flared tip (PE-90, Clay Adams, Parsippany, NJ,
USA) was inserted into the dome of the bladder and secured
with a ligature for bladder filling and pressure recording. The
abdominal wall and overlying skin were closed with a suture.
The rat was then mounted on a tilt table with the axis of rota-
tion positioned for constant bladder height in relation to the
pressure transducer, either in the supine or vertical position.
To measure the intravesical pressure, normal saline was infused
through the polyethylene catheter that was inserted into the
animal’s bladder. The catheter is connected to the microsy-
ringe pump (KD Scientific, Holliston, MA, USA) and the
pressure measurement system via a 3-way stopcocks. Data
generated by the pressure sensor (ADInstruments, Colorado-
springs, CO, USA) and bridge amplifier (ADInstruments,
Powerlab
� 2/25, Coloradosprings, CO, USA) were analyzed.
All bladder pressure was referenced to air pressure at the
level of bladder. The rats were placed at the level of zero pres-
sure while bladders were filled with room temperature saline
at 5 mL/hr through the bladder catheter. The rats were then
mounted on a tilt table and placed in the vertical position.
The pressure at leak point was taken as the LLP. The average
of three consecutive LPP was taken as a data point for each
animal.
Tissue preparation and histology
Immediately after the LPP measurement, the rats were euth-
anized, and the proximal urethra was removed. The tissue
samples for fluorescent microscopy were prepared by snap
freezing of the urethra, embedding in OCT compound (Tis-
sue Tek; Sakura Finekek USA, Torrance, CA, USA). Sections
were cut (5 mm) and used for fluorescent dye staining. Spec-
imens for light microscopy were fixed in 10% formaldehyde,
embedded in paraffin, and cut to obtain 5 mm thick sections.
These sections were deparaffinated, hydrated, and stained with
hematoxylin-eosin and Masson’s trichrome. All staining were
performed using standard methods, and all reagents were
from Sigma-Aldrich (St.Louis, MO, USA).
Fluorescent microscopy and prussian blue staining
Tissues were cut into 10 mm pieces (axial) and snap frozen
for sectioning at 5 mm thickness. Tissue sections were cover
slipped using aqueous mounting media containing 40, 6-
diamidino-2-phenylindole (DAPI; Vector Shield, Vector Lab-
oratories Inc., Burlingame, CA, USA) to outline the nucleus.
Fluorescent-labeled cells were detected and photographed
using a fluorescent microscope. Following fluorescent pho-
tomicrography, slides were dismounted and tissue sections
were stained for iron using Prussian blue staining technique.
Bright field photomicrographs were obtained from the same
sites with same magnification to determine whether fluores-
cent positive cells were also iron positive.
All immunofluorescent labeling and dyes were examined
using a Carl Zeiss LSM 510 Meta confocal laser scanning
microscope equipped with 488 nm argon ion, 543 nm green
helium-neon, and 633 nm red helium-neon laser lines. Three-
dimensional images were reconstructed by several consecu-
tive optical sections of various thicknesses (0.25-0.38 mm).
Immunohistochemistry for detecting desmin 
Formalin-fixed, paraffin-embedded tissues were sectioned
at 5 mm thickness. These sections were deparaffinated, rehy-
drated, and pretreated with 3% H2O2 for 10 min at room
temperature. Then antigen retrieval was performed in boil-
ing 10mM citrate acid buffer (pH6.0) for 10 min followed
by cooling at room temperature for 20 min. Then the sec-
tions were incubated in 10% normal goat serum in PBS for
1 hr at room temperature followed by incubation with pri-
mary antibody (mouse anti-desmin monoclonal antibody,
abcam ab17156, Abcam Inc, Cambridge, MA) at 4℃ over-
night. Sections were incubated with horseradish peroxidase-
conjugated goat-anti mouse IgG (Vector Laboratory Inc. Bur-
lingame, CA, USA) for 15 min at room temperature. DAB
chromogen was used for color development under the light
microscope and the sections were counterstained with hema-
toxylin.
Statistical analysis
LPP data are presented as means±SD. Overall compar-
isons between groups were performed using a one-way anal-
ysis of variance for within time-point analyses and two-way
analysis of variance for across time-point analyses. Individual
comparisons were made using Student’s t-test. A P value of
less than 0.05 was accepted as significant.
RESULTS
The LPP in HUCB mononuclear cell-injected rats
Fig. 1 shows the LPP values measured using vertical tilt/
intravesical pressure clamp technique at 2 and 4 weeks after
the injection. The LPP values were slightly higher in the ex-
perimental group, but not statistically different at 2 weeks.
The mean value for the control group (n=8) was 46.13±12.14
mmHg, and the value for the experimental group (n=9) was
55.72±9.99 mmHg at 2 weeks. But, the LPP values were
Umbilical Cord Blood Mononuclear Cell for Urethral Sphincter Function 665significantly increased in the experimental group at 4 weeks
while the control group did not show significant change in
LPP value (mean LPP for control group (n=14): 65.02±22.09
mmHg, for the experimental group (n=19): 91.75±18.99
mmHg, P=0.001, t=-3.728, within 95% validity interval).






















Fig. 1. Comparative effect of HUCB mononuclear cell injection on
leak point pressure between groups at 2 and 4 weeks. *is signifi-
cantly different from each other (P<0.05) at each time. Compared
with control group, the leak point pressure in the experimental
group at 4 week after HUCB mononuclear cell injection was sig-
nificantly increased.
Fig. 2. Photographs show Feridex
�-labeled HUCB mononuclear
cells in urethral tissue at 2 weeks post-injection. A number of cells
considered human cells within the tissue sections were detected
by blue-colored signals. (A, C) Control group; (B, D) Experimen-








Fig. 3. Photographs show Di-I labeled HUCB mononuclear cells in urethral tissue at 2 weeks post-injection. A number of cells considered
human cells within the tissue sections were detected by red-colored Di-I signals (A, B, Di-I stained cells; C, Control group; D-F, Experimen-
tal group. A, D are DIC images. B and E are fluorescence images).
A
DIC DiI Merge
B C 100 mm 100 mm 50 mm
DIC DiI Merge
50 mm 50 mm 50 mm D E FHUCB mononuclear cells in the urethral wall in the
experimental group at 2 weeks and 4 weeks
Iron-stained, fluorescent-labeled HUCB mononuclear cells
were found in the lamina propria and in the muscular urethral
sphincter in the experimental group at 2 weeks (Figs. 2, 3).
The human cells were mainly found in the lamina propria
just beneath the urethral mucosa. A few cells were also noted
in the sphincter skeletal muscle layer. Some of the cells were
small, round cells with scant cytoplasm and some were big-
ger with abundant cytoplasm. A few of the cells just beneath
the mucosa were spindle shaped. We could not find any iron-
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Fig. 4. Photographs show sphincter muscle disruption and collagen deposit in the control group (A) at 4 weeks after injection. Sphincter
muscles in the experimental group (B) were well preserved and intact, and with no collagen deposit (H&E, ×400).
A B
Fig. 5. The immunohistochemical stainings for desmin and trichrome stain show apparent sphincter muscle disruption and collagen deposit




TRC TRCstained or fluorescent-labeled cells in the rat urethral tissue
at 4 weeks. The control group rats did not show any iron-
stained or fluorescent-labeled human cells at 2 weeks and 4
weeks.
The morphological integrity of the internal urethral sphincter
No significant morphological difference in the urethral
sphincter muscle was observed at 2 weeks between the exper-
imental group and control group. At 4 weeks after the elec-
tro-cauterization, however, obvious disruption of the urethral
sphincter muscle was apparent in the control group, while
the sphincter muscle in the experimental group injected with
HUCB mononuclear cells was largely restored to the mor-
phological integrity of the intact urethral sphincter (Figs. 2-
4). The immunohistochemical staining to desmin showed
the disrupted arrangement of skeletal muscle layer of the ure-
thral sphincter in the control group while in the experimen-
tal group, the sphincter remained well-organized (Fig. 5). In
the control group, collagen was deposited at the disrupted
area, which was confirmed by the blue color on trichrome
staining. On the other hand, collagen deposit was not observed
in the experimental group injected with HUCB mononu-
clear cells (Fig. 5).
DISCUSSION
Various types of tissue have been tried as the source of stem
cells in the stem cell therapy for ISD in animal studies. Autol-
ogous bone marrow-derived stem cells have been one of the
most common sources used for the mesenchymal or poten-
tially myogenic stem cells, but harvesting of mesenchymal
stem cells from bone marrow aspirate is difficult with low
yield and the procedure of bone marrow procurement is pain-
ful (13). Muscle-derived stem cells, myoblasts, or satellite
cells, alleged muscle progenitor cells, have also been tried.
Yiou et al. reported regeneration of an injured rat rhabdom-
yosphincter with intrinsic satellite cells (5). Yokoyama et al.
(14) injected muscle-derived progenitor cells, MDPCs, in
the normal rat urethra and observed better durability than
obtained by treatment with bovine collagen. Cannon et al.
(9) injected allogenic muscle-derived progenitor cells in the
urethra of a rat with severed nerves and reported enhanced
contractability of the sphincter. 
Nevertheless, the use of umbilical cord blood stem cells for
treatment of urinary incontinence had never been attempted
before. Since Rocha et al. (15) successfully performed cord
blood transplantation for Fanconi anemia in 1988, cord blood
transplantation has been performed frequently as a substitute
for bone marrow transplantation. It also has been investigat-
ed in many animal models of various degenerative diseases,
such as spinal cord injury model and cerebral ischemia model,
with some promising results (16-18). Umbilical cord blood
is more easily applicable as a donor because of its less strin-
gent HLA matching requirements due to its immunologic
inertness and subsequent lower chance of graft versus host
disease (GVHD). Furthermore, the specimen collection is
easier and the risk of viral contamination is lower.
In this study, we induced ISD in rats with electro-cauteri-
zation and injected mononuclear cells isolated from human
umbilical cord blood to investigate the efficacy of HUCB
mononuclear cells as a source of stem cell therapy in ISD. LPP
values measured in 4 weeks by vertical tilt/intravesical pres-
sure clamp model were significantly higher in the experimen-
tal group. The urethral rhabdosphincter of the experimental
group remained well-organized and intact while the saline-
treated control group showed severe degeneration and dis-
ruption of the sphincter muscle layers. No animals showed
clinical or histological features of rejection, GVHD or infec-
tion. All these results showed that HUCB mononuclear cells
may be an effective and safe treatment option for ISD, suggest-
ing the role of umbilical cord blood as an alternative source
for stem cell therapy.
The mechanism how the injected HUCB mononuclear
cells act on the urethral sphincter is not yet understood. It
was speculated that the injected stem cells might migrate
to the demanded site and differentiate to skeletal muscular
cells and repair the injured sphincter muscle. HUCB stem
cells have been shown to differentiate into diverse cell lin-
eages, including myogenic, chondrogenic, and insulin-pro-
ducing cells (19-21). In our study, the injected HUCB mono-
nuclear cells were noted to be localized around the urethral
sphincter. The majority of them were noted in the lamina
propria beneath the urethral mucosa but a few of them were
found between the muscle layers of the sphincter, implicat-
ing that the cells play roles in repairing the injured muscle
and maintaining the sphincter muscle intact. The injected
stem cells in this study might also have differentiated into
skeletal muscle cells. Interestingly a few of the iron positive
cells noted around the urethral tissue were spindle shaped
rather than round, suggesting mesenchymal differentiation.
However, unfortunately, we failed to identify the cellular lin-
eage of the iron-positive cells from the tissue sections due to
absence of myoid antibody specific to human. Four weeks after
the transplantation, we could no longer detect any human-
derived iron-positive cells around the urethral tissue, despite
the significant histological difference observed. The iron in
the injected cells might have been already metabolized at that
point. It is also possible that the injected cells might have
been phagocytosed and lost with only very few of them en-
grafted and able to function. Identification of grafted stem
cells in host organs has always been a matter of debate in ani-
mal model studies of stem cell therapy (22, 23). Some demon-
strated grafted cells viable after quite a long period of time
while others could not or could only prove very few in num-
bers (22, 24-26).
Another postulated mechanism is that in stem cell thera-
668 J.-J. Lim, J.-B. Jang, J.-Y. Kim, et al.py, it is not the direct transdifferentiation of injected stem
cells that actually affect the recovery of the injured tissue.
Instead, the injected cells might rather stimulate the intrin-
sic stem cells in a paracrine way to help them proliferate and
differentiate (27). It has also been speculated that it is the effect
of growth factors or cytokines used in the culture media that
might have been injected together with the cells. In this study,
we could exclude the possibility of exogenous cytokines as
we used only normal saline for cell suspension. However, the
possibility of de novo paracrine effects from injected cells can-
not be completely ruled out. Actually in recent years, the
opinion that it is the paracrine effect, not the replacement of
injured tissue by transdifferentiation of stem cells which pro-
motes the recovery/regeneration of damaged tissue is gaining
more support with repeated laboratory observations (28).
While it is still in debate how stem cells work in recovery
of the damaged tissue, numerous studies have shown that stem
cell therapy can improve the functional capacity of the dam-
aged organs, at least temporarily (28). Some even demonstrat-
ed functional improvement in long term period (23, 29). Al-
though we cannot positively guarantee the long term effect
from our study alone, which remains to be proved, the results
from these long term studies are encouraging.
We believe that HUCB mononuclear cell is worth as an
alternative source of stem cells as it is easier to obtain than
other sources and safely applicable without significant adverse
effects, yet with noticeable therapeutic efficacy, which we
demonstrated in our study.
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